Keyphrases
ST-elevation Myocardial Infarction (STEMI)
100%
Primary Percutaneous Coronary Intervention
48%
Percutaneous Coronary Intervention
26%
Infarct Size
25%
Clinical Outcomes
19%
Acute Myocardial Infarction
16%
Cardiac Magnetic Resonance
16%
Cardiac Magnetic Resonance Imaging (cMRI)
16%
Final Infarct Size
14%
Fractional Flow Reserve
14%
Myocardial Infarction Patients
12%
Myocardial Salvage
11%
Revascularization
11%
Left Ventricular Function
10%
Left Ventricular Ejection Fraction
10%
Myocardial Infarction
10%
Randomized Clinical Trial
10%
Confidence Interval
10%
Cardiovascular Magnetic Resonance
9%
Complete Revascularization
9%
Myocardial Salvage Index
9%
Hazard Ratio
9%
Area at Risk
8%
Randomized Controlled Trial
7%
Ischemic Preconditioning
7%
Culprit Lesion
7%
All-cause Mortality
7%
Alirocumab
7%
Small Vessel Disease
7%
Reperfusion
7%
Reperfusion Failure
6%
Magnetic Resonance Imaging
6%
Myocardial Area at Risk
6%
Exenatide
6%
Placebo
6%
Transcatheter Aortic Valve Implantation
6%
Heart Failure
5%
Ischemia
5%
Symptom Onset
5%
Left Atrial Function
5%
Deferred Stenting
5%
Cardioprotection
5%
Myocardial Injury
5%
Optical Coherence Tomography
5%
Pac-Man
5%
Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
68%
Primary Percutaneous Coronary Intervention
32%
Cardiac Magnetic Resonance Imaging
30%
Infarction
29%
Percutaneous Coronary Intervention
26%
Revascularization
16%
Myocardial Infarction
16%
Fractional Flow Reserve
13%
Acute Heart Infarction
11%
Percutaneous Aortic Valve Replacement
8%
Stenosis
7%
Heart Left Ventricle Ejection Fraction
7%
Coronary Artery Disease
7%
Hazard Ratio
7%
Randomized Controlled Trial
6%
Heart Failure
6%
Stenting
6%
Magnetic Resonance Imaging
6%
Artery
5%
Alirocumab
5%
Symptom
5%
Heart Left Ventricle Function
5%
Disease
5%
Optical Coherence Tomography
5%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
82%
Infarction
40%
Heart Infarction
17%
Acute Heart Infarction
14%
Randomized Clinical Trial
11%
Placebo
11%
Heart Failure
9%
Heart Muscle Injury
7%
All Cause Mortality
7%
Exendin 4
6%